---
title: "Siemens Healthineers AG and others v Hologic, Inc. (UPC CoA 93/2026, 15-07-2026)"
description: "The Court of Appeal refused to suspend a Düsseldorf Local Division infringement decision against Siemens Healthineers companies."
url: https://pitch.law/academy/upc-court-of-appeal/upc-coa-93-2026-2026-07-15
lang: en
author: "UPC Case Law by Pitch"
editor: "Bart Lieben"
datePublished: 2026-11-18T10:07:37.485Z
dateModified: 2026-11-18T10:07:37.485Z
---

# Siemens Healthineers AG and others v Hologic, Inc.

Order of the UPC Court of Appeal of 15 July 2026, UPC CoA 93/2026.

UPC Case Law by Pitch, edited by [Bart Lieben](https://pitch.law/team/bart-lieben) · Published 18-11-2026

## TL;DR

The Court of Appeal refused to suspend a Düsseldorf Local Division infringement decision against Siemens Healthineers companies. It held that a first-instance claim construction differing from the appellant's is not manifestly erroneous, and that a court respects the right to be heard if its decision reflects a party's core arguments, even briefly and in different words. Appellants seeking suspensive effect on right-to-be-heard grounds face a high bar.

## Key holding

Under Art 76(2) UPCA the right to be heard obliges the court to take note of and give due consideration to the parties' submissions, and to address the essential substance of submissions on a central issue in its reasoning. An infringement must be presumed only where the grounds allow no conclusion other than that the submissions were completely disregarded, or where they capture at most the literal wording but not the meaning of the submissions. The court need not expressly and exhaustively address every argument; at least the parties' core arguments must be reflected in the decision.

## Questions decided

1. When does an appeal exceptionally get suspensive effect under Art 74(1) UPCA?
2. Is a claim construction that differs from the appellant's a manifest error?
3. What does the right to be heard under Art 76(2) UPCA require in a decision's reasoning?
4. Is an injunction covering 'making' manifestly wrong against defendants who did not manufacture the product?

## Case details

- Court: Court of Appeal of the Unified Patent Court, Panel 3
- Panel: Ulrike Voß (presiding judge and judge-rapporteur); Bart van den Broek (legally qualified judge); Nathalie Sabotier (legally qualified judge)
- Date: 15-07-2026
- Case number(s): UPC CoA 93/2026, UPC CFI 758/2024, UPC CFI 259/2025
- Parties: Appellants: Siemens Healthineers AG, Siemens Healthcare GmbH, Siemens Healthineers Nederland B.V. and Siemens Healthcare SAS (defendants at first instance); Respondent: Hologic, Inc. (claimant at first instance)
- Language of the proceedings: English
- Outcome: The application for suspensive effect was rejected. It was admissible but not well-founded (para 15).

## How to cite

Court of Appeal, Siemens Healthineers AG and others v Hologic, Inc., UPC CoA 93/2026, Order of 15 July 2026 (OSCOLA)

## Full summary

Read the full analyses for free — create a free account: https://pitch.law/academy/upc-court-of-appeal/upc-coa-93-2026-2026-07-15

Topics: [Infringement and claim interpretation](https://pitch.law/academy/upc-court-of-appeal/topics/infringement), [Suspensive effect and enforcement](https://pitch.law/academy/upc-court-of-appeal/topics/suspensive-effect-and-enforcement)

## More on infringement and claim interpretation

- [Barco N.V. v Yealink (Xiamen) Network Technology Co., Ltd. and others, UPC CoA 145/2026, 16-10-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-145-2026-2026-10-16): The Court of Appeal upheld the Brussels Local Division's refusal to let Barco add a late auxiliary request (AR6) whose claim 1 is identical to dependent claim 9, a claim neither asserted for infringement nor attacked in the counterclaim for revocation.
- [Hurom Co., Ltd. v NUC Electronics Co., Ltd and others, UPC CoA 678/2025, 28-08-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-678-2025-2026-08-28): The Court of Appeal upheld the Paris Local Division's revocation of Hurom's juicer patent EP 3 155 936 (as amended) for lack of inventive step, refused Hurom's new auxiliary requests filed only on appeal, and confirmed dismissal of all infringement claims, including those for Poland.
- [Hartmann Packaging A/S v Omni-Pac Ekco GmbH Verpackungsmittel and others, UPC CoA 908/2025, 19-08-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-908-2025-2026-08-19): The Court of Appeal rejected Hartmann's infringement and revocation appeals on its egg-package patent EP 2 755 901.
- [Lepu Medical Technology (Bejing) Co., Ltd and others v Occlutech GmbH, UPC CoA 87/2026, 17-08-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-87-2026-2026-08-17): The Court of Appeal upheld a EUR 58,800 penalty against the Lepu companies for breaching a preliminary injunction (PI), and rejected their appeal in full.
- [Nera Innovations Ltd v Xiaomi Communications Co., Ltd. and others, UPC CoA 692/2025, 30-06-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-692-2025-2026-06-30): The Court of Appeal excluded from the appeal a private expert report on claim interpretation, an accompanying handbook extract, and a new inventive-step attack based on D1, D2 and D4, because Xiaomi could have filed them at first instance and gave no reason for not doing so.
- [Occlutech GmbH v Lepu Medical (Europe) Cooperatief U.A. and others, UPC CoA 907/2025, 18-06-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-907-2025-2026-06-18): The Court of Appeal set aside the Düsseldorf Local Division's refusal of provisional measures and itself ordered Lepu to stop offering and marketing its MemoCarna ASD and VSD occluders in Germany, France, Italy and the Netherlands.
